dr. brahmer explains pd-1 and pd-l1
Published 10 years ago • 1.2K plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
1:53
dr. brahmer on the role of pd-1 and pd-l1
-
1:16
explaining immunotherapy, pd-l1 and pd-1
-
1:15
dr. brahmer on immunotherapy beyond pd-1/l1 in nsclc
-
1:21
dr. julie brahmer on the pd-1 targeted immunotherapy bms-93655 clinical trial
-
4:00
cancer immunotherapy - pd-1 and pd-l1
-
27:53
navigating challenges with pd-l1 combined positive score (cps)
-
1:02:49
pd-l1/pd-1 cancer immunotherapy and new targets - gordon freeman, phd
-
3:21
pd-l1/pd-1 pathway: a security checkpoint
-
1:34
dr. ribas on pd-1 and pd-l1 in cancer
-
2:12
cancer immunotherapy | the pd-l1 pathway
-
3:29
pd-l1/pd-1 pathway: a security checkpoint
-
26:40
the basic biology of pd-1/pd-l1
-
2:57
car brakes: pd-1/pd-l1 molecular pathway explained
-
36:47
the status of pd-l1 testing and what is next? | presented by dr. ming tsao
-
6:56
all you need to know about pd-l1 by immunohistochemistry
-
1:57
targeting pd-1 and pd-l1 for lung cancer therapy
-
1:48
dr. brahmer discusses frontline single-agent pembrolizumab in lung cancer
-
1:00
dr. mason on the reliability of the pd-l1 biomarker
-
9:19
exploring the pd-1/pd-l1 pathway using data, tools, and resources from rcsb.org
-
4:15
pathologists and pd-l1
-
2:01
dr. welsh on new understanding of regulating pd-l1 expression
-
18:58
pd-l1 testing by immunohistochemistry